These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32206094)

  • 21. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.
    Gonzalez SA; Perrillo RP
    Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S306-13. PubMed ID: 27190320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
    Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
    Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases.
    Onorato L; Pisaturo M; Camaioni C; Grimaldi P; Codella AV; Calò F; Coppola N
    J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.
    Kato M; Atsumi T
    Rheumatol Int; 2016 May; 36(5):635-41. PubMed ID: 26573663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis.
    Moghoofei M; Mostafaei S; Ashraf-Ganjouei A; Kavosi H; Mahmoudi M
    Microb Pathog; 2018 Jan; 114():436-443. PubMed ID: 29223453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons learned from chemotherapeutic and immunosuppressant induced Hepatitis B reactivation - a case series.
    Nida' Ul-Huda A; Haniza O
    Med J Malaysia; 2021 Sep; 76(5):719-724. PubMed ID: 34508381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations.
    Bessone F; Dirchwolf M
    World J Hepatol; 2016 Mar; 8(8):385-94. PubMed ID: 27004086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of resolved hepatitis B virus infection combined with nephrotic syndrome in a patient after allogeneic haematopoietic stem cell transplantation.
    Zhang JW; Zhang XZ; Sun YL; Long B; Wang XZ; Li XD
    BMC Infect Dis; 2019 Jan; 19(1):57. PubMed ID: 30651070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders.
    Viganò M; Serra G; Casella G; Grossi G; Lampertico P
    Expert Opin Biol Ther; 2016 Jul; 16(7):917-26. PubMed ID: 27088278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
    Fukuda W; Hanyu T; Katayama M; Mizuki S; Okada A; Miyata M; Handa Y; Hayashi M; Koyama Y; Arii K; Kitaori T; Hagiyama H; Urushidani Y; Yamasaki T; Ikeno Y; Suzuki T; Omoto A; Sugitani T; Morita S; Inokuma S
    Ann Rheum Dis; 2017 Jun; 76(6):1051-1056. PubMed ID: 27934678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing.
    Sakamoto K; Umemura T; Ito K; Okumura A; Joshita S; Ota M; Sugiyama M; Mizokami M; Yoneda M; Tanaka E
    J Infect Dis; 2020 Jan; 221(3):400-407. PubMed ID: 31550370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases.
    Wang J; Zhang X; Geng X; Shi J; Jia X; Dang S; Wang W
    EClinicalMedicine; 2022 Jun; 48():101425. PubMed ID: 35706497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
    Bonifati C; Lora V; Graceffa D; Nosotti L
    World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of Hepatitis B reactivation in the setting of immunosuppression.
    Pattullo V
    Clin Mol Hepatol; 2016 Jun; 22(2):219-37. PubMed ID: 27291888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations.
    Piaserico S; Messina F; Russo FP
    Am J Clin Dermatol; 2019 Dec; 20(6):829-845. PubMed ID: 31222626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B and Hepatitis C Reactivation in the Biologic Era.
    Bojito-Marrero L; Pyrsopoulos N
    J Clin Transl Hepatol; 2014 Dec; 2(4):240-6. PubMed ID: 26355300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis.
    Su J; Long L; Zou K
    Clin Rheumatol; 2018 Dec; 37(12):3201-3214. PubMed ID: 29637482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy.
    Phipps C; Chen Y; Tan D
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):5-11. PubMed ID: 26705677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.